MDCX
Medicus Pharma·NASDAQ
--
--(--)
--
--(--)
MDCX Filings
Filing Date
Form Description
Form Type
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06
Form 253G2 -
2026-03-06 ·
Form 253G2 -
2026-03-06
Form 8-K - Current report
Key Events
2026-03-06 · Key Events
Form 8-K - Current report
2026-02-05
Form EFFECT - Notice of Effectiveness
2026-02-05 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form S-3 - Registration statement under Securities Act of 1933
2026-01-30 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-12
Form DRS - Draft Registration Statement
2026-01-12 ·
Form DRS - Draft Registration Statement
2026-01-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
